SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-23-025698
Filing Date
2023-04-03
Accepted
2023-03-31 18:41:36
Documents
13
Period of Report
2023-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K ea176287-8ka_abvcbio.htm   iXBRL 8-K/A 28627
2 PRESS RELEASE ea176287ex99-1_abvcbio.htm EX-99.1 100988
  Complete submission text file 0001213900-23-025698.txt   317174

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abvc-20230331.xsd EX-101.SCH 2965
4 XBRL LABEL FILE abvc-20230331_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE abvc-20230331_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT ea176287-8ka_abvcbio_htm.xml XML 3679
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40700 | Film No.: 23789771
SIC: 2834 Pharmaceutical Preparations